SOPHiA GENETICS (SOPH) and AstraZeneca Spain (AZN) Commit to Increasing Ovarian Cancer Testing in Spain
Go back to SOPHiA GENETICS (SOPH) and AstraZeneca Spain (AZN) Commit to Increasing Ovarian Cancer Testing in Spain| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 1,503,821 | |||||
| (NASDAQ: SOPH) | Delayed: 5.23 -0.11 (2.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.34 | 52 Week High | $ | |||
| Open | $5.29 | 52 Week Low | $ | |||
| Day High | $5.35 | P/E | N/A | |||
| Day Low | $5.08 | EPS | $ | |||
| Volume | 111,091 | |||||

